|
시장보고서
상품코드
2126001
신장 바이오마커 시장(2026-2030년)Global Renal Biomarkers Market 2026-2030 |
||||||
세계의 신장 바이오마커 시장은 2025년부터 2030년까지 16억 1,030만 달러 증가하고, 예측 기간 동안 CAGR은 13.7%에 달할 것으로 예측됩니다.
세계 신장 바이오마커 시장에 관한 본 보고서는 종합적인 분석, 시장 규모 및 전망, 동향, 성장 요인, 과제뿐만 아니라 약 25개 업체를 대상으로 한 업체 분석을 제공합니다.
본 보고서는 현재의 시장 상황, 최신 동향 및 성장 요인, 그리고 전반적인 시장 환경에 대한 최신 분석을 제공합니다. 이 시장의 성장을 주도하는 요인은 전 세계 신장질환 유병률의 증가, 신약 개발 및 진단 기술의 발전, 그리고 조기 발견과 맞춤형 의료로의 패러다임 전환입니다.
본 조사는 업계 주요 관계자들의 의견을 포함한 1차 정보와 2차 정보를 객관적으로 결합하여 수행되었습니다. 본 보고서에는 주요 기업에 대한 분석 외에도 종합적인 시장 규모 데이터, 지역별 분석을 포함한 부문, 그리고 벤더 현황이 포함되어 있습니다. 보고서에는 과거 데이터 및 예측 데이터가 수록되어 있습니다.
| 시장 범위 | |
|---|---|
| 기준 연도 | 2025년 |
| 종료 연도 | 2030년 |
| 조사 기간 | 2026-2030년 |
| 성장 모멘텀 | 가속 |
| 2026년 전년 대비 | 12.5% |
| CAGR | 13.7% |
| 증가액 | 16억 1,030만 달러 |
본 조사에서는 향후 수년간 전 세계 신장 바이오마커 시장의 성장을 견인할 주요 요인 중 하나로, 현장 진단(Point-of-Care) 검사의 보급 확대가 꼽히고 있습니다. 또한, 멀티플렉스 바이오마커 패널에 대한 집중과 AI 및 기계 학습의 통합을 통해 시장에서 상당한 수요가 발생할 것으로 전망됩니다.
목차
제1장 주요 요약
제2장 Technavio 분석
제3장 시장 구도
제4장 시장 규모
제5장 시장 규모 실적
제6장 정성 분석
제7장 Five Forces 분석
제8장 시장 세분화 : 최종사용자별
제9장 시장 세분화 : 유형별
제10장 시장 세분화 : 진단법별
제11장 고객 상황
제12장 지역별 상황
제13장 촉진요인, 과제, 기회
제14장 경쟁 구도
제15장 경쟁 분석
제16장 부록
KSM 26.09.08The global renal biomarkers market is forecasted to grow by USD 1610.3 mn during 2025-2030, accelerating at a CAGR of 13.7% during the forecast period. The report on the global renal biomarkers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global prevalence of kidney diseases, technological advancements in discovery and diagnostics, paradigm shift toward early detection and personalized medicine.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 12.5% |
| CAGR | 13.7% |
| Incremental Value | $1610.3 mn |
Technavio's global renal biomarkers market is segmented as below:
By End-User
- Hospitals
- Clinics and diagnostic laboratories
- Research laboratories
By Type
- Functional biomarkers
- Upregulated protein biomarkers
- Others
By Diagnostic Methods
- Enzyme-linked immunosorbent assay
- Particle-enhanced turbidimetric immunoassay
- Colorimetric assay
- Chemiluminescent immunoassay
- Others
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the increasing adoption of point-of-care testing as one of the prime reasons driving the global renal biomarkers market growth during the next few years. Also, emphasis on multiplex biomarker panels and integration of ai and machine learning will lead to sizable demand in the market.
The report on the global renal biomarkers market covers the following areas:
- Global renal biomarkers market sizing
- Global renal biomarkers market forecast
- Global renal biomarkers market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global renal biomarkers market vendors that include Abbott Laboratories, Beckman Coulter Inc., Bio Techne Corp., BioMerieux SA, BioPorto AS, BioVendor LM, CUSABIO Technology LLC, DiaSys Diagnostic Systems, Elabscience Biotechnology Inc., F. Hoffmann La Roche Ltd., Gentian Diagnostics ASA, Getein Biotech Inc., Guangzhou Wondfo Biotech Co Ltd, Hycult Biotech B.V., Randox Laboratories Ltd., Sekisui Diagnostics LLC, Shenzhen Mindray Co. Ltd., Siemens Healthineers AG, Snibe Co.Ltd.. Also, the global renal biomarkers market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Diagnostic Methods
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Renal Biomarkers Market 2020 - 2024
- Historic Market Size - Data Table on Global Renal Biomarkers Market 2020 - 2024 ($ million)
- 5.2 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.3 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- 5.4 Diagnostic Methods segment analysis 2020 - 2024
- Historic Market Size - Diagnostic Methods Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Renal Biomarkers Market
- 6.2 Impact of Geopolitical Conflicts on Global Renal Biomarkers Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by End-user
- 8.1 Market segments
- 8.2 Comparison by End-user
- 8.3 Hospitals - Market size and forecast 2025-2030
- 8.4 Clinics and diagnostic laboratories - Market size and forecast 2025-2030
- 8.5 Research laboratories - Market size and forecast 2025-2030
- 8.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
9 Market Segmentation by Type
- 9.1 Market segments
- 9.2 Comparison by Type
- 9.3 Functional biomarkers - Market size and forecast 2025-2030
- 9.4 Upregulated protein biomarkers - Market size and forecast 2025-2030
- 9.5 Others - Market size and forecast 2025-2030
- 9.6 Market opportunity by Type
- Market opportunity by Type ($ million)
10 Market Segmentation by Diagnostic Methods
- 10.1 Market segments
- 10.2 Comparison by Diagnostic Methods
- 10.3 Enzyme-linked immunosorbent assay - Market size and forecast 2025-2030
- 10.4 Particle-enhanced turbidimetric immunoassay - Market size and forecast 2025-2030
- 10.5 Colorimetric assay - Market size and forecast 2025-2030
- 10.6 Chemiluminescent immunoassay - Market size and forecast 2025-2030
- 10.7 Others - Market size and forecast 2025-2030
- 10.8 Market opportunity by Diagnostic Methods
- Market opportunity by Diagnostic Methods ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 Turkey - Market size and forecast 2025-2030
- 12.6.5 South Africa - Market size and forecast 2025-2030
- 12.6.6 Israel - Market size and forecast 2025-2030
- 12.6.7 Argentina - Market size and forecast 2025-2030
- 12.6.8 Colombia - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Rising global prevalence of kidney diseases
- Technological advancements in discovery and diagnostics
- Paradigm shift toward early detection and personalized medicine
- 13.2 Market challenges
- High cost and reimbursement hurdles
- Regulatory complexity and stringent validation requirements
- Barriers to clinical adoption and integration
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Increasing adoption of point-of-care testing
- Emphasis on multiplex biomarker panels
- Integration of AI and machine learning
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
- 15.5 Beckman Coulter Inc.
- Beckman Coulter Inc. - Overview
- Beckman Coulter Inc. - Product / Service
- Beckman Coulter Inc. - Key offerings
- SWOT
- 15.6 Bio Techne Corp.
- Bio Techne Corp. - Overview
- Bio Techne Corp. - Business segments
- Bio Techne Corp. - Key news
- Bio Techne Corp. - Key offerings
- Bio Techne Corp. - Segment focus
- SWOT
- 15.7 BioMerieux SA
- BioMerieux SA - Overview
- BioMerieux SA - Business segments
- BioMerieux SA - Key offerings
- BioMerieux SA - Segment focus
- SWOT
- 15.8 BioVendor LM
- BioVendor LM - Overview
- BioVendor LM - Product / Service
- BioVendor LM - Key offerings
- SWOT
- 15.9 CUSABIO Technology LLC
- CUSABIO Technology LLC - Overview
- CUSABIO Technology LLC - Product / Service
- CUSABIO Technology LLC - Key offerings
- SWOT
- 15.10 Elabscience Biotechnology Inc.
- Elabscience Biotechnology Inc. - Overview
- Elabscience Biotechnology Inc. - Product / Service
- Elabscience Biotechnology Inc. - Key offerings
- SWOT
- 15.11 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 15.12 Getein Biotech Inc.
- Getein Biotech Inc. - Overview
- Getein Biotech Inc. - Product / Service
- Getein Biotech Inc. - Key offerings
- SWOT
- 15.13 Guangzhou Wondfo Biotech Co Ltd
- Guangzhou Wondfo Biotech Co Ltd - Overview
- Guangzhou Wondfo Biotech Co Ltd - Product / Service
- Guangzhou Wondfo Biotech Co Ltd - Key offerings
- SWOT
- 15.14 Randox Laboratories Ltd.
- Randox Laboratories Ltd. - Overview
- Randox Laboratories Ltd. - Product / Service
- Randox Laboratories Ltd. - Key offerings
- SWOT
- 15.15 Sekisui Diagnostics LLC
- Sekisui Diagnostics LLC - Overview
- Sekisui Diagnostics LLC - Product / Service
- Sekisui Diagnostics LLC - Key offerings
- SWOT
- 15.16 Shenzhen Mindray Co. Ltd.
- Shenzhen Mindray Co. Ltd. - Overview
- Shenzhen Mindray Co. Ltd. - Business segments
- Shenzhen Mindray Co. Ltd. - Key offerings
- Shenzhen Mindray Co. Ltd. - Segment focus
- SWOT
- 15.17 Siemens Healthineers AG
- Siemens Healthineers AG - Overview
- Siemens Healthineers AG - Business segments
- Siemens Healthineers AG - Key offerings
- Siemens Healthineers AG - Segment focus
- SWOT
- 15.18 Snibe Co.Ltd.
- Snibe Co.Ltd. - Overview
- Snibe Co.Ltd. - Product / Service
- Snibe Co.Ltd. - Key offerings
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
